Lantern Pharma (LTRN) EBITDA Yield: History & Chart

Lantern Pharma Inc.(LTRN)

Biotechnology · Dallas, TX

$0.97+0.03 (+3.35%)

Delayed quote: Oct 6, 2026, 2:43 PM EDT

About Lantern Pharma Inc.

Lantern Pharma Inc. is a clinical-stage biotechnology firm dedicated to revolutionizing drug development through the strategic application of artificial intelligence, machine learning, and comprehensive genomic data analysis. Their primary drug candidate, LP-100, is currently undergoing Phase II clinical trials, targeting metastatic, castration-resistant prostate cancer. The company is also advancing LP-300 as a potential combination therapy for non-small cell lung cancer adenocarcinoma, specifically in individuals who are non-smokers or have never smoked. Furthermore, their preclinical pipeline includes LP-184, an alkylating agent engineered to inflict DNA damage upon cancer cells that either overexpress specific biomarkers or exhibit mutations within their DNA repair pathways. Beyond these, Lantern Pharma maintains an antibody-drug conjugate (ADC) program for diverse cancer treatments. Central to their operations is the RADR artificial intelligence platform, which synergizes molecular data through advanced big data analytics and machine learning capabilities. Established in 2013, the company operates from its headquarters in Dallas, Texas.

Dallas, TX

16 employees

www.lanternpharma.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Panna Sharma

View full financials

NAME	MARKET CAP	EBITDA YIELD	TTM	3Y	5Y
Lantern Pharma Inc. (LTRN)	$12.40M	N/A	N/A	N/A	N/A
Cellectar Biosciences, Inc. (CLRB)vs ›	$12.46M	N/A	N/A	N/A	N/A
Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs ›	$12.49M	N/A	N/A	N/A	N/A
Tempest Therapeutics, Inc. (TPST)vs ›	$12.43M	N/A	0.00%	0.00%	0.00%
Dare Bioscience, Inc. (DARE)vs ›	$12.54M	N/A	N/A	N/A	N/A
Cytosorbents Corporation (CTSO)vs ›	$12.60M	N/A	N/A	N/A	N/A
IRIDEX Corporation (IRIX)vs ›	$12.12M	N/A	0.96%	2.71%	3.80%
Biofrontera Inc. (BFRI)vs ›	$11.76M	N/A	N/A	N/A	N/A
Passage Bio, Inc. (PASG)vs ›	$13.08M	N/A	N/A	N/A	N/A
IN8bio, Inc. (INAB)vs ›	$12.95M	N/A	N/A	N/A	N/A

NAME

MARKET CAP

EBITDA YIELD

TTM

Lantern Pharma Inc. (LTRN)

$12.40M

N/A

Cellectar Biosciences, Inc. (CLRB)vs ›

$12.46M

N/A

Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs ›

$12.49M

N/A

Tempest Therapeutics, Inc. (TPST)vs ›

$12.43M

N/A

0.00%

Dare Bioscience, Inc. (DARE)vs ›

$12.54M

N/A

Cytosorbents Corporation (CTSO)vs ›

$12.60M

N/A

IRIDEX Corporation (IRIX)vs ›

$12.12M

N/A

0.96%

2.71%

3.80%

Biofrontera Inc. (BFRI)vs ›

$11.76M

N/A

Passage Bio, Inc. (PASG)vs ›

$13.08M

N/A

IN8bio, Inc. (INAB)vs ›

$12.95M

N/A

EBITDA Yield Formula & Definition

EBITDA Yield = TTM EBITDA / Enterprise Value

EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.

EBITDA Yield: N/A

LTRN EBITDA Yield Metrics

LTRN Competitors' EBITDA Yield

EBITDA Yield Formula & Definition

Related Metrics